Briacell Therapeutics Corp (BCT)
$0.95 -$0.03 (-3.16%) 4:38 PM 12/13/24
TSX | $CAD | BiotechnologyStock Data
-
Market Cap
$59.70M -
Day's Range
CA$0.88 - CA$0.98 -
Volume
115,035 -
52 Week Low / High
CA$0.64 - CA$8.00 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
BCT's Dividend
Company News
-
BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study — May 28th, 2024
BriaCell Therapeutics Corp. Study to evaluate the effects of Bria-OTS™ in combination with anti-PD-1 antibody tislelizumab, in advanced, late stage, heavily pretreated metastatic breast cancer. PHILADELPHIA and VANCOUVER, British Columbia, May 28, 2024 (GLOBE NEWSWIRE) -- BriaCell Ther...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$